110 related articles for article (PubMed ID: 8088321)
1. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
[TBL] [Abstract][Full Text] [Related]
2. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation.
Reist CJ; Combs MJ; Croft BY; Taylor RP
Eur J Immunol; 1993 Nov; 23(11):3021-7. PubMed ID: 8223879
[TBL] [Abstract][Full Text] [Related]
3. Primate erythrocyte (E) complement receptor (CR1) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation.
Taylor RP; Ferguson PJ
J Hematother; 1995 Oct; 4(5):357-62. PubMed ID: 8581369
[TBL] [Abstract][Full Text] [Related]
4. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
Taylor RP; Sutherland WM; Martin EN; Ferguson PJ; Reinagel ML; Gilbert E; Lopez K; Incardona NL; Ochs HD
J Immunol; 1997 Jan; 158(2):842-50. PubMed ID: 8993002
[TBL] [Abstract][Full Text] [Related]
5. In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor.
Taylor RP; Reist CJ; Sutherland WM; Otto A; Labuguen RH; Wright EL
J Immunol; 1992 Apr; 148(8):2462-8. PubMed ID: 1373171
[TBL] [Abstract][Full Text] [Related]
6. Antigen-based heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys.
Ferguson PJ; Martin EN; Greene KL; Kuhn S; Cafiso DS; Addona G; Taylor RP
J Immunol; 1995 Jul; 155(1):339-47. PubMed ID: 7602110
[TBL] [Abstract][Full Text] [Related]
7. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model.
Taylor RP; Martin EN; Reinagel ML; Nardin A; Craig M; Choice Q; Schlimgen R; Greenbaum S; Incardona NL; Ochs HD
J Immunol; 1997 Oct; 159(8):4035-44. PubMed ID: 9378993
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model.
Kuhn SE; Nardin A; Klebba PE; Taylor RP
J Immunol; 1998 May; 160(10):5088-97. PubMed ID: 9590260
[TBL] [Abstract][Full Text] [Related]
9. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
10. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
11. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
Edberg JC; Kimberly RP; Taylor RP
Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
[TBL] [Abstract][Full Text] [Related]
13. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model.
Nardin A; Schlimgen R; Holers VM; Taylor RP
Eur J Immunol; 1999 May; 29(5):1581-6. PubMed ID: 10359112
[TBL] [Abstract][Full Text] [Related]
14. Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen.
Craig ML; Reinagel ML; Martin EN; Schlimgen R; Nardin A; Taylor RP
Clin Immunol; 1999 Aug; 92(2):170-80. PubMed ID: 10444361
[TBL] [Abstract][Full Text] [Related]
15. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates.
Birmingham DJ; Hebert LA; Cosio FG; VanAman ME
J Lab Clin Med; 1990 Aug; 116(2):242-52. PubMed ID: 1697615
[TBL] [Abstract][Full Text] [Related]
16. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
17. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
Taylor RP; Wright EL; Pocanic F
J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
[TBL] [Abstract][Full Text] [Related]
19. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
Emlen W; Burdick G; Carl V; Lachmann PJ
J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
[TBL] [Abstract][Full Text] [Related]
20. Heteropolymers: a novel technology against blood-borne infections.
Mohamed N; Jones SM; Casey LS; Pincus SE; Spitalny GL
Curr Opin Mol Ther; 2005 Apr; 7(2):144-50. PubMed ID: 15844622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
